Crescita Therapeutics (TSE:CTX) Trading Down 7.4% – Time to Sell?

Crescita Therapeutics Inc. (TSE:CTX)’s stock price traded down 7.4% during mid-day trading on Tuesday . The company traded as low as C$0.43 and last traded at C$0.44. 57,401 shares traded hands during trading, an increase of 197% from the average session volume of 19,351 shares. The stock had previously closed at C$0.47.

Crescita Therapeutics Stock Down 13.0%

The firm has a 50-day moving average price of C$0.46 and a 200 day moving average price of C$0.48. The company has a debt-to-equity ratio of 5.77, a current ratio of 2.70 and a quick ratio of 2.29. The company has a market cap of C$7.45 million, a price-to-earnings ratio of 20.00 and a beta of -0.02.

Crescita Therapeutics (TSE:CTX) last released its quarterly earnings results on Wednesday, November 5th. The company reported C$0.04 earnings per share for the quarter. The business had revenue of C$5.39 million during the quarter. Crescita Therapeutics had a negative return on equity of 15.60% and a negative net margin of 15.73%.

About Crescita Therapeutics

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin.